Abstract
The current political and societal climate is driving the science of toxicology towards developing non-animal testing methodologies. Though alternative and in vitro tests have always been a mainstay for toxicological testing, technological advances in the last decade have allowed toxicologists to move rapidly towards a better understanding of the relevance of in vitro endpoints for traditional apical endpoints. Non-animal research using new technologies have illuminated toxicologists on the mechanisms of protection and adverse health outcomes. In this context, the “validation” of alternative and in vitro tests has taken on significant importance, particularly in regard to satisfying safety concerns of drugs and chemicals in a regulatory setting. The purpose of this chapter is to briefly review the impetus for the development of alternative and in vitro tests, discuss the projects underway at the ILSI Health and Environmental Sciences Institute (HESI) that are oriented towards this topic, and summarize the processes for formal validation. It should be noted that though there are validated assays and tests, these are under constant evaluation by scientific researchers as our understanding of the underlying biological processes continues to evolve.
Key words
- In vitro
- Alternative tests
- Validation
- Developmental
- Reproductive
- Toxicology
This is a preview of subscription content, access via your institution.
Buying options
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
http://ec.europa.eu/consumers/sectors/cosmetics/animal-testing/index_en.htm. Accessed 26 Aug 2011
http://ec.europa.eu/environment/chemicals/reach/reach_intro.htm. Accessed 26 Aug 2011
http://ec.europa.eu/environment/chemicals/reach/pdf/reach_animal_testing.pdf. Accessed 26 Aug 2011
Scialli AR (2008) The challenge of reproductive and developmental toxicology under REACH. Regul Toxicol Pharmacol 51:244–250
http://www.reprotect.eu/. Accessed 28 Sept 2011
http://www.acutetox.eu/. Accessed 28 Sept 2011
National Research Council (U.S.). Committee on Toxicity Testing and Assessment of Environmental Agents (2007) Toxicity testing in the 21st century: a vision and a strategy. National Academies Press, Washington, DC
http://www.epa.gov/ncct/toxcast/. Accessed 26 Aug 2011
http://www.epa.gov/ncct/Tox21/. Accessed 26 Aug 2011
ICCVAM (2003) ICCVAM guidelines for the nomination and submission of new, revised, and alternative test methods. http://iccvam.niehs.nih.gov/SuppDocs/SubGuidelines/SD_subg034508.pdf. Accessed 28 Sept 2011
Balls M, Blaauboer B, Brusick D, Frazier J, Lamb D, Pemberton M, Reinhardt C, Roberfroid M, Rosenkranz H, Schmid B, Spielmann H, Stammati A-L, Walum E (1990) Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. Altern Lab Anim 18:313–337
Smith LL, Brent RL, Cohen SM, Doerrer NG, Goodman JI, Greim H, Holsapple MP, Lightfoot RM (2008) Predicting future human and environmental health challenges: the Health and Environmental Sciences Institute’s scientific mapping exercise. Crit Rev Toxicol 38:817–845
Bonnefoi MS, Belanger SE, Devlin DJ, Doerrer NG, Embry MR, Fukushima S, Harpur ES, Hines RN, Holsapple MP, Kim JH, MacDonald JS, O’Lone R, Pettit SD, Stevens JL, Takei AS, Tinkle SS, van der Laan JW (2010) Human and environmental health challenges for the next decade (2010–2020). Crit Rev Toxicol 40:893–911
Chapin R, Augustine-Rauch K, Beyer B, Daston G, Finnell R, Flynn T, Hunter S, Mirkes P, O’Shea KS, Piersma A, Sandler D, Vanparys P, Van Maele-Fabry G (2008) State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res B Dev Reprod Toxicol 83:446–456
Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H (2010) Identification of a primary target of thalidomide teratogenicity. Science 327:1345–1349
Shuey D, Kim JH (2011) Overview: developmental toxicology-new directions. Birth Defects Res B Dev Reprod Toxicol 92(5):381–383. doi:10.1002/bdrb.20312
Makris SL, Kim JH, Ellis A, Faber W, Harrouk W, Lewis JM, Paule MG, Seed J, Tassinari M, Tyl R (2011) Current and future needs for developmental toxicity testing. Birth Defects Res B Dev Reprod Toxicol 92(5):384–394. doi:10.1002/bdrb.20335
Carney EW, Ellis AL, Tyl RW, Foster PM, Scialli AR, Thompson K, Kim J (2011) Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater. Birth Defects Res B Dev Reprod Toxicol 92(5):395–403. doi:10.1002/bdrb.20318
Brannen K, Fenton SE, Hansen DK, Harrouk W, Kim JH, Shuey D (2011) Developmental toxicology: new directions workshop: refining testing strategies and study designs. Birth Defects Res B Dev Reprod Toxicol 92(5):404–412. doi:10.1002/bdrb.20326
Knudsen TB, Kavlock RJ, Daston GP, Stedman D, Hixon M, Kim JH (2011) Developmental toxicity testing for safety assessment: new approaches and technologies. Birth Defects Res B Dev Reprod Toxicol 92(5):413–420. doi:10.1002/bdrb.20315
Sasaki J, Chapin R, Hall D, Breslin W, Moffit J, Saldutti L, Enright B, Seger M, Jarvi K, Hixon M, Mitchard T, Kim JH (2011) Incidence and nature of testicular toxicity findings in pharmaceutical development. Birth Defects Res B Dev Reprod Toxicol 92(6):511–525. doi:10.1002/bdrb.20338
Smith MK, Kimmel GL, Kochhar DM, Shepard TH, Spielberg SP, Wilson JG (1983) A selection of candidate compounds for in vitro teratogenesis test validation. Teratog Carcinog Mutagen 3:461–480
Schwetz BA (1992) Criteria for judging the relative toxicity of chemicals from developmental toxicity data: a workshop summary. Teratology 45:337–339
Brown NA (2002) Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30:177–198
Genschow E, Spielmann H, Scholz G, Seiler A, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K (2002) The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30:151–176
Marx-Stoelting P, Adriaens E, Ahr HJ, Bremer S, Garthoff B, Gelbke HP, Piersma A, Pellizzer C, Reuter U, Rogiers V, Schenk B, Schwengberg S, Seiler A, Spielmann H, Steemans M, Stedman DB, Vanparys P, Vericat JA, Verwei M, van der Water F, Weimer M, Schwarz M (2009) A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect workshop. Altern Lab Anim 37:313–328
Daston GP, Chapin RE, Scialli AR, Piersma AH, Carney EW, Rogers JM, Friedman JM (2010) A different approach to validating screening assays for developmental toxicity. Birth Defects Res B Dev Reprod Toxicol 89:526–530
http://ecvam.jrc.it/. Accessed 26 Aug 2011
Hartung T, Bremer S, Casati S, Coecke S, Corvi R, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Roi AJ, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V (2004) A modular approach to the ECVAM principles on test validity. Altern Lab Anim 32:467–472
http://iccvam.niehs.nih.gov/. Accessed 26 Aug 2011
http://iccvam.niehs.nih.gov/methods/development/dev.htm. Accessed 28 Sept 2011
http://jacvam.jp/en/. Accessed 26 Aug 2011
http://sc.bcrc.cn/col/1253668419437/1303811031404.html. Accessed 26 Aug 2011
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kim, J.H. (2013). Validation of Alternative Tests for Developmental and Reproductive Toxicology Testing: An ILSI Health and Environmental Sciences Institute Perspective. In: Barrow, P. (eds) Teratogenicity Testing. Methods in Molecular Biology, vol 947. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-131-8_32
Download citation
DOI: https://doi.org/10.1007/978-1-62703-131-8_32
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-130-1
Online ISBN: 978-1-62703-131-8
eBook Packages: Springer Protocols